Acute rejection in donation after circulatory death (DCD) heart transplants

Selena S Li1, Masaki Funamoto2, Asishana A Osho1

  • 1Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Insights

Donation after circulatory death (DCD) heart transplants show similar early survival to donation after brain death (DBD) transplants, but DCD recipients face a higher risk of acute rejection. Further research is needed on long-term outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Donation after circulatory death (DCD) heart transplantation offers potential for increased organ availability.
  • Early survival rates for DCD heart transplants are promising.
  • The impact of DCD on acute rejection remains an area requiring further clarification.

Purpose of the Study:

  • To compare the incidence of acute rejection in adult heart transplant recipients between DCD and DBD donors.
  • To identify predictors of acute rejection in DCD versus DBD heart transplant recipients.

Main Methods:

  • Analysis of the United Network for Organ Sharing database for adult heart transplants between December 2019 and December 2021.
  • Exclusion of multiorgan transplants and patients lost to follow-up.
  • Primary outcome: acute rejection, comparing DCD and donation after brain death (DBD) cohorts.

Main Results:

  • DCD recipients (n=292) were less likely to require mechanical support (IABP, ECMO, LVAD) or be hospitalized pre-transplant compared to DBD recipients (n=5,582).
  • DCD recipients demonstrated a higher likelihood of acute rejection before discharge (23.3% vs 18.4%) and hospitalization for rejection (23.4% vs 11.4%) at 15-month follow-up.
  • DCD donation independently predicted acute rejection (OR 1.47) and hospitalization for rejection (OR 2.03), with higher rates observed in subgroup analyses.

Conclusions:

  • DCD heart transplant recipients exhibit a significantly higher incidence of acute rejection compared to DBD recipients.
  • While early survival is comparable, the increased early rejection in DCD recipients warrants further investigation into long-term implications.
  • The findings suggest a need for optimized immunosuppression protocols or closer monitoring for DCD heart transplant recipients.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
28
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
394
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
356